Literature DB >> 2460407

Toxoid of Pseudomonas aeruginosa exotoxin A generated by deletion of an active-site residue.

M Lukac1, G B Pier, R J Collier.   

Abstract

Glutamic acid-553 of Pseudomonas aeruginosa exotoxin A (ETA), identified previously as an active-site residue, was deleted by oligonucleotide-directed mutagenesis of the cloned toxin gene in Escherichia coli. The purified mutant toxin was stable, fully immunoreactive, and capable of blocking toxin receptors. ADP-ribosyltransferase and cytotoxic activities were at least 10(6)-fold lower than those of wild-type ETA, and injection of mice with 50 micrograms (equivalent to 400 lethal doses of ETA) produced no ill effects. The mutant toxin elicited high levels of neutralizing anti-ETA antibodies in mice, which protected against a challenge with 100 micrograms of authentic ETA (greater than 600 lethal doses). The mutant protein has the attributes of a toxoid and may be useful as a component of vaccines for individuals at risk for infection by P. aeruginosa.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2460407      PMCID: PMC259707          DOI: 10.1128/iai.56.12.3095-3098.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.609


  23 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.

Authors:  O R Pavlovskis; M Pollack; L T Callahan; B H Iglewski
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

3.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

4.  Experimental studies of the pathogenesis of infections due to Pseudomonas aeruginosa: extracellular protease and elastase as in vivo virulence factors.

Authors:  I A Holder; C G Haidaris
Journal:  Can J Microbiol       Date:  1979-05       Impact factor: 2.419

5.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

6.  Pseudomonas exotoxin A: toxoid preparation by photoaffinity inactivation.

Authors:  S Marburg; R L Tolman; L T Callahan
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

7.  Isolation and characterization of a Pseudomonas aeruginosa mutant producing a nontoxic, immunologically crossreactive toxin A protein.

Authors:  S J Cryz; R L Friedman; B H Iglewski
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

8.  Evidence for the role of toxin A in the pathogenesis of infection with Pseudomonas aeruginosa in humans.

Authors:  A S Cross; J C Sadoff; B H Iglewski; P A Sokol
Journal:  J Infect Dis       Date:  1980-10       Impact factor: 5.226

9.  Exotoxin A of Pseudomonas aeruginosa: evidence that domain I functions in receptor binding.

Authors:  C Guidi-Rontani; R J Collier
Journal:  Mol Microbiol       Date:  1987-07       Impact factor: 3.979

10.  Clinical significance of serum antibody responses to exotoxin A and type-specific lipopolysaccharides in patients with Pseudomonas aeruginosa infections.

Authors:  M Pollack; R N Longfield; W W Karney
Journal:  Am J Med       Date:  1983-06       Impact factor: 5.928

View more
  16 in total

1.  Engineering of genetically detoxified pertussis toxin analogs for development of a recombinant whooping cough vaccine.

Authors:  S M Loosmore; G R Zealey; H A Boux; S A Cockle; K Radika; R E Fahim; G J Zobrist; R K Yacoob; P C Chong; F L Yao
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

2.  Reversion of recombinant toxoids: mutations in diphtheria toxin that partially compensate for active-site deletions.

Authors:  K P Killeen; V Escuyer; J J Mekalanos; R J Collier
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

3.  Immunogenic properties of Pseudomonas aeruginosa mucoid exopolysaccharide.

Authors:  C V Garner; D DesJardins; G B Pier
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

4.  ABT-737 promotes the dislocation of ER luminal proteins to the cytosol, including pseudomonas exotoxin.

Authors:  Antonella Antignani; Robert Sarnovsky; David J FitzGerald
Journal:  Mol Cancer Ther       Date:  2014-04-16       Impact factor: 6.261

5.  Characterization of a cellular protease that cleaves Pseudomonas exotoxin.

Authors:  C Fryling; M Ogata; D FitzGerald
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.609

6.  Dual-function vaccine for Pseudomonas aeruginosa: characterization of chimeric exotoxin A-pilin protein.

Authors:  R Hertle; R Mrsny; D J Fitzgerald
Journal:  Infect Immun       Date:  2001-11       Impact factor: 3.609

7.  Host translational inhibition by Pseudomonas aeruginosa Exotoxin A Triggers an immune response in Caenorhabditis elegans.

Authors:  Deborah L McEwan; Natalia V Kirienko; Frederick M Ausubel
Journal:  Cell Host Microbe       Date:  2012-04-19       Impact factor: 31.316

8.  Assessment of the impact of manufacturing changes on the physicochemical properties of the recombinant vaccine carrier ExoProtein A.

Authors:  Martin Burkhardt; Karine Reiter; Vu Nguyen; Motoshi Suzuki; Raul Herrera; Patrick E Duffy; Richard Shimp; Nicholas J MacDonald; L Renee Olano; David L Narum
Journal:  Vaccine       Date:  2018-09-24       Impact factor: 4.169

9.  Comparative immunogenicity of conjugates composed of the Staphylococcus aureus type 8 capsular polysaccharide bound to carrier proteins by adipic acid dihydrazide or N-succinimidyl-3-(2-pyridyldithio)propionate.

Authors:  A Fattom; J Shiloach; D Bryla; D Fitzgerald; I Pastan; W W Karakawa; J B Robbins; R Schneerson
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.609

10.  Use of high density cultures of Escherichia coli for high level production of recombinant Pseudomonas aeruginosa exotoxin A.

Authors:  R Fass; M van de Walle; A Shiloach; A Joslyn; J Kaufman; J Shiloach
Journal:  Appl Microbiol Biotechnol       Date:  1991-10       Impact factor: 5.560

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.